483
Cosmax USA, Inc.Cosmax USA, Inc. – FDA 483, Jul 22, 2022
Record Details
An FDA inspection of Cosmax USA, Inc. in Solon, OH, revealed a significant deficiency in laboratory controls. Specifically, the firm failed to establish scientifically sound and appropriate test procedures, as method validations for stability testing of two drug products, Broad Spectrum SPF 40 and Sunscreen, did not demonstrate stability-indicating properties. This issue led to the release of numerous batches of these drug products without adequate assurance of their stability.
View Company Profile
ID · a71ee26e-99ef-432c-a848-d6ffd20165e2
Other documents for Cosmax USA, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.